3654 results for «370»
3654 results
Patent foramen ovale (PFO) closure with stroke
18 May 2021 – From EuroPCR 2021
Watch this session presented by Engin Bozkurt in order to know more about incidence about stroke caused to younger people, to follow the guideline trend towards patent foramen ovale (PFO) closure, and to learn the future of PFO and device trends.
Complex PCI in complex patients
28 Apr 2021 – From EuroPCR 2021
Watch this session to learn more about various existing ways to treat the culprit vessel during TAVI, double CTO on ECMO following in-hospital cardiac arrest, acute ST-elevation myocardial infarction and heavily calcified lesion, STEMI and cardiogenic shock, and more!
When percutaneous treatment saved the day!
12 May 2021 – From EuroPCR 2021
Get prepared in case of sudden severe dyspnoea, find out more about late presentation myocardial Infarction, discover penetrating trauma caused by a screwdriver, and more in this session!
Usefulness of intracoronary imaging in your daily practice
12 May 2021 – From EuroPCR 2021
Thanks to this session, discover a surprising finding in a chronic coronary syndrome, get proof that IVUS can be essential to guide bifurcation stenting, face ACS with left main disease dilemma, among others!
Complex rotational atherectomy
12 May 2021 – From EuroPCR 2021
This session will be useful if you wish to find out more about heavy coronary calcification and wire entrapment, underestimated type A lesion, no-option critical 3 vessel CAD, and more!
Guiding primary PCI using high-definition intravascular ultrasound
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.
Clinical event reductions in high-risk hypertension patients treated with renal denervation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...
BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes
18 May 2021 – From EuroPCR 2021
Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
Transfemoral TAVI in the horizontal aorta
12 May 2020
Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
